Cancer prevalence estimates in Europe at the beginning of 2000Gemma Gatta, Fabio Falcini, Sabine Siesling et al.|Annals of Oncology|2013Cited by 44
146P HRD/TIL-low high-risk breast cancer is characterized by good prognosis (the RADIMMUNE trial)B. Pellegrino, A. Musolino, A. Llop-Guevara et al.|Annals of Oncology|2022Cited by 1